S505N mutation is additionally found but significantly less frequently than in hereditary thrombocytosis. Rarer mutations of MPL Autonomous activation on the JAK/STAT pathway is central in a number of pathologies. Genetic alterations targeting this signaling pathway are connected largely with hematologic malignancies. Pathological JAK activation also takes place in diseases https://judyk318bgk2.wikiap.com/user